More from this creator
Other episodes by Kitty Cat.
More like this
If you liked this, try these.
Transcript
The full episode, in writing.
Here are the four most significant European health policy organizations and initiatives shaping public health across the continent as of June and July 2024.
EU4Health’s Coordinated Approach
EU4Health is a major European Union health program created to strengthen healthcare systems across EU member states. The program was launched in 2021 in response to the COVID-19 pandemic, which exposed serious vulnerabilities and disparities in health infrastructure among EU countries. One of EU4Health’s core objectives is to mitigate the kind of healthcare disparities that emerged during the pandemic, in areas such as preparedness, response capability, and access to care.
The program is funded and implemented directly by the European Union. With a total allocation of €5.1 billion between 2021 and 2027, EU4Health is the largest health program ever financed by the EU. This scale of funding is intended to address the complex needs of 27 member states, plus associated countries, and to support projects that reinforce the resilience and capacity of national health systems.
EU4Health has four primary objectives. The first is crisis preparedness and management, which aims to strengthen the capacity of EU countries to prevent, prepare for, and respond to serious cross-border health threats. This includes developing strategic medical stockpiles, enhancing early warning and surveillance systems, and supporting national and EU-level response capabilities.
The second objective is to improve access to medicines and support innovation. EU4Health works to ensure that EU citizens have access to affordable medicines, vaccines, and medical equipment. The program seeks to reduce dependence on non-EU supply chains and to promote the development and availability of innovative health products and technologies.
The third objective focuses on strengthening health systems and the healthcare workforce. EU4Health supports national systems by improving their resilience, capacity, and efficiency. This includes providing funding and training opportunities for healthcare professionals, fostering cross-border cooperation, and enhancing digital health infrastructure to enable secure data sharing and telemedicine.
The fourth major objective is prevention and health promotion. EU4Health supports initiatives that encourage EU citizens to adopt healthier lifestyles. The program funds public health information campaigns and disease prevention efforts, with targeted actions on cancer, mental health, as well as communicable and non-communicable diseases.
EU4Health’s governance and oversight are managed centrally at the EU level. The European Commission, working in collaboration with the European Parliament and the Council of the European Union, is responsible for the strategic direction of the program. The day-to-day management and distribution of funds are handled by the European Health and Digital Executive Agency. EU4Health also coordinates with national health authorities, the European Centre for Disease Prevention and Control, and the European Medicines Agency to align its work with broader EU health policies and ensure consistency across countries.
Key Initiatives and Actions
EU4Health funds a broad array of activities designed to directly achieve its objectives. One of the central initiatives is the support for the European Health Emergency Preparedness and Response Authority. This authority was created to coordinate the response to health emergencies across the EU, such as pandemics or chemical threats, by sharing resources, information, and expertise.
The program makes significant investments in digital health transformation. This includes funding the development of the European Health Data Space, a digital infrastructure project enabling secure, interoperable health data sharing across member states. By linking health data while maintaining strict privacy safeguards, the European Health Data Space is expected to improve research, patient care, and cross-border healthcare delivery.
Cancer prevention and care have become signature areas of focus within EU4Health. The program supports initiatives aligned with Europe’s Beating Cancer Plan, targeting early detection, diagnosis, treatment, and survivorship care. These efforts are designed to reduce disparities in cancer outcomes between countries and regions, and to strengthen national cancer control programs.
The program also targets mental health, with a series of programs addressing the pandemic’s impact, youth mental health, mental health in the workplace, and suicide prevention. By funding research, community interventions, and awareness campaigns across continent-wide networks, EU4Health seeks to improve recognition, access, and support for mental health challenges.
Workforce development is another funded area. EU4Health provides grants and training opportunities to healthcare professionals in order to address skill shortages, promote exchange of expertise, and foster collaboration between countries. Cross-border training modules and digital upskilling are key features aimed at modernizing the European health workforce.
EU4Health’s impact is subject to ongoing assessment. Regular reviews are conducted to evaluate whether funded projects are meeting objectives in improving health outcomes, reducing inequalities, and enhancing system resilience. These reviews inform future perspectives and adjustments, ensuring the program remains responsive to emerging threats and technological advances.
In December 2025, the Council of the European Union agreed on the Critical Medicines Act, which aims to address shortages of essential health products such as antibiotics and insulin. The act introduces incentives for diversifying supply chains and boosting pharmaceutical manufacturing within the EU, directly complementing EU4Health’s objectives for access to medicines and supply resilience.
In December 2025, a newly dominant flu strain led to high or very high influenza activity in at least 27 of 38 countries in the WHO’s European region. This surge placed significant pressure on healthcare systems, underscoring the importance of EU4Health’s crisis preparedness investments and support for coordinated, cross-border responses to health emergencies.
As of July 2026, the European Union Drugs Agency and the UK government signed a working arrangement to boost information exchange on new drug threats, newly detected substances, and emerging risks. This enhances both sides’ capacity to identify and respond to drug-related health threats, reflecting the EU-wide trend toward stronger cross-border health threat preparedness.
Slovenia’s abolition of healthcare co-payments in 2024, cited in an October 2025 WHO report, is highlighted as a model reform for universal health coverage. This example of national-level innovation aligns with EU4Health’s broader aim to reduce inequalities and to strengthen financial protection for patients.
Role of EuroHealthNet
EuroHealthNet is a Brussels-based non-profit partnership, founded in 1996, that works to promote health and health equity across Europe. The organization’s mission is to reduce avoidable health inequalities both between and within European countries. Its work is rooted in the principle that the highest attainable standard of health is a fundamental right for all people, regardless of their social, economic, or demographic background.
EuroHealthNet operates by collaborating with agencies, statutory bodies, and organizations at national, regional, and EU levels. With its office in the City of Brussels and a staff of about twenty, EuroHealthNet is well-positioned to engage directly with EU institutions and to influence policy agendas. The organization’s partnership framework brings together public authorities, civil society, academia, and private sector stakeholders to share evidence, develop projects, and advocate for public health policies.
Three interlinked platforms structure EuroHealthNet’s work: PRACTICE, POLICY, and RESEARCH. These platforms enable the organization to support project implementation, shape policy development, and generate evidence in a coordinated manner.
EuroHealthNet has played a leading role in highlighting the scale and urgency of health inequalities in Europe. For example, there is a documented gap of over a decade in life expectancy at birth between EU member states. In 2012, the life expectancy for Swedish males was 81 years, while for Lithuanian males it was 68.4 years, a difference of more than twelve years. The disparities are even greater when considering healthy life years, which measure years lived without significant disability. In 2012, Estonian males were predicted to have 18.4 fewer healthy life years than males born in Malta.
The organization addresses these gaps by supporting integrated approaches that tackle the social determinants of health – the economic, educational, environmental, and social factors that shape health outcomes. EuroHealthNet works to build the evidence base for public health interventions that target the root causes of inequalities, rather than simply treating their consequences.
EuroHealthNet’s activities include policy advocacy, such as influencing EU and national health strategies; developing and managing projects in fields like chronic disease, mental health, and childhood development; and supporting evidence-based policymaking. The organization has contributed input to major EU strategies, such as the 2020 EU growth strategy, which recognizes the need to fight social and health inequalities as prerequisites for growth and competitiveness.
EuroHealthNet also promotes health literacy, sustainable lifestyles, vaccination, digital health, and social protection. Through its projects and platforms, the organization works to improve health promotion and disease prevention systems, which are essential to narrowing health gaps and improving population health.
The partnership supports members’ work by providing expertise on health equity, sharing best practices, and facilitating communication with EU decision makers. This enables local and regional health agencies to connect with European-level policy development, ensuring that the realities of health inequalities are reflected in legislation and funding priorities.
Health First Europe’s Contributions
Health First Europe is a Brussels-based non-profit organization focused on promoting patient-centered healthcare and improving access to innovative medical technologies across Europe. The organization functions as an alliance of patients, healthcare workers, academics, healthcare experts, and the medical technology industry, reflecting a broad coalition of interests in health system modernization.
The group comprises 20 member organizations and 10 individual members, including notable figures such as Günter Neubauer, a professor of economics and social policy at the University of the Bundeswehr in Germany, and Elias Mossialos, a professor of health policy at the London School of Economics and Political Science. The diverse membership enables Health First Europe to advocate from multiple perspectives, bridging the interests of patients, clinicians, industry, and policy experts.
Health First Europe’s central goal is to ensure equitable access to modern, reliable medical technology for all European citizens. The organization identifies weaknesses in European healthcare systems and argues that a structural rethink is required to meet current and future health challenges. One of its guiding principles is that health is not only a right but also a productive economic factor. Improved health outcomes contribute to employment, innovation, and broader economic growth.
Health First Europe advocates for the development of flexible modes of healthcare delivery that benefit both patients and providers. This includes promoting home-based care, telemedicine, and other technology-enabled care models to supplement traditional hospital-based services. By supporting innovation in healthcare delivery, the organization works to increase system sustainability and patient satisfaction.
Patient safety is a core focus. Health First Europe campaigns for increased attention to safety standards, the integration of evidence-based protocols, and the adoption of new medical technologies that reduce errors and improve outcomes. The organization also highlights the importance of healthcare system sustainability, calling for investments that ensure reliable access to high-quality care even as populations age and disease burdens shift.
Health First Europe’s influence on policy is rooted in its ability to convene stakeholders and provide expert input to EU forums. The organization raises awareness of barriers to technology adoption, such as regulatory fragmentation and funding limitations, and supports policy solutions that facilitate the diffusion of medical innovations across borders.
The organization’s advocacy has contributed to EU policy discussions around essential medicine availability, as seen with the Critical Medicines Act and the broader objectives of EU4Health. Health First Europe also participates in debates on workforce shortages, skills gaps, and the urgent need for digital upskilling in the health sector.
The group’s members include organizations such as the European Patients Forum, the European Federation of Crohn’s and Ulcerative Colitis Associations, the International Diabetes Federation – Europe, and the European Health Telematics Society. This broad network allows Health First Europe to represent patient and professional interests in pan-European policy dialogues.
By supporting access to innovative treatments and promoting patient-centered care models, Health First Europe contributes to a health policy environment that values both technological progress and health equity. Its work complements the government-driven efforts of EU4Health, providing a civil society perspective that emphasizes the practical realities of health service delivery and patient experience.
As of the most recent data, the combined efforts of EU4Health, EuroHealthNet, and Health First Europe are shaping a more resilient, equitable, and innovative public health landscape in Europe. One example of this coordinated approach is the support for the European Health Data Space, which, funded in part through EU4Health, is designed to enable the secure and interoperable sharing of health data across EU member states. This digital infrastructure is intended to accelerate medical research and improve patient outcomes by allowing healthcare providers to access comprehensive patient information regardless of country.
In July 2026, the World Health Organization released new guidance on the repair, refurbishment, and recycling of assistive technology, aiming to improve access and sustainability for essential health devices. This reflects the ongoing drive to ensure that health innovations reach all segments of the population, a core principle echoed by both Health First Europe and EuroHealthNet.
In July 2026, the UK government and the European Union Drugs Agency signed a working arrangement to enhance information exchange on drug-related threats. This reciprocal agreement will help both sides to identify emerging risks earlier and respond more effectively, further demonstrating the increasing importance of cross-border coordination in European health policy.